By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Nuformix plc (NFX.L)

LSE Currency in GBP
£0.09
£0.00
+3.67%
Last Update: 16 Jul 2025, 15:35
£1.80M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
£0.04 - £0.30
52 Week Range

NFX.L Stock Price Chart

Explore Nuformix plc interactive price chart. Choose custom timeframes to analyze NFX.L price movements and trends.

There is nothing to show.

NFX.L Company Profile

Discover essential business fundamentals and corporate details for Nuformix plc (NFX.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

17 Dec 2015

Employees

3.00

CEO

Daniel John Gooding

Description

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.

NFX.L Financial Timeline

Browse a chronological timeline of Nuformix plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 30 Apr 2026

Upcoming earnings on 27 Jan 2026

Earnings released on 2 May 2025

EPS came in at -£0.00.

Earnings released on 29 Jan 2025

EPS came in at £0.00.

Earnings released on 18 Jun 2024

EPS came in at -£0.00.

Earnings released on 19 Mar 2024

EPS came in at -£0.00.

Earnings released on 22 May 2023

EPS came in at -£0.00.

Earnings released on 24 Jan 2023

EPS came in at £0.00.

Earnings released on 28 Jul 2022

EPS came in at -£0.00.

Earnings released on 14 Dec 2021

EPS came in at -£0.00, while revenue for the quarter reached £50.00K.

Earnings released on 15 Jul 2021

EPS came in at -£0.00.

Earnings released on 22 Dec 2020

EPS came in at -£0.00, while revenue for the quarter reached £195.55K.

Earnings released on 23 Jul 2020

EPS came in at -£0.00.

NFX.L Stock Performance

Access detailed NFX.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
NFX.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
NFX.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More